I specialize in multiple myeloma, a blood cancer of the bone marrow plasma cells that can cause bone damage and kidney problems. I also treat other conditions caused by abnormal growth of plasma cells, such as light chain amyloidosis, which can affect the heart and kidneys, and POEMS syndrome.

My research focuses on outcomes of patients with multiple myeloma treated with chimeric antigen receptor T-cell therapies and novel bispecific antibodies. I am a member of the U.S. Multiple Myeloma Immunotherapy Consortium and have more than 50 peer-reviewed publications.